| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | US20040082795 Asymmetric catalytic hydrogenation process for preparation of chiral cyclic beta-aminoesters |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082642 Novel estrogen receptor ligands and method III |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 04/29/2004 | US20040082612 Analgesics, antiinflammatory agents, autoimmune diseases; central nervous system disorders, psychological disorders, drug abuse, alcoholism, cardiovascular disorders |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082610 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082563 Thrombosis therapy; antitumor agents; anticoagulants; Factor x inhibitors; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 04/29/2004 | US20040081620 Measurement anticoagulant |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
| 04/29/2004 | CA2500417A1 Neurotrophic factor production promoter |
| 04/28/2004 | EP1413302A2 Substituted guanidines for the treatment of pain |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1411946A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 04/28/2004 | EP1411943A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP0719253B1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 04/28/2004 | CN1491942A Non humidity suction stable crystalline form of N-[N-N-(4-piperidine-4-yl)-N-ethyl glycyl) compound |
| 04/28/2004 | CN1147504C New thrombin inhibitors, their preparation and use |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/28/2004 | CN1147471C Renin inhibitors |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/28/2004 | CN1147329C Device for trandermal electrotransport delivery of fentanyl and sufentanil |
| 04/27/2004 | US6727368 Oligomers and polymers of cyclic imino carboxylic acids |
| 04/27/2004 | US6727300 Photo/thermal stability over time |
| 04/27/2004 | US6727264 Substituted anilinic piperidines as MCH selective antagonists |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | CA2299400C Method for treating disease-related or drug-induced dyskinesias |
| 04/22/2004 | WO2004033444A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 04/22/2004 | WO2004033429A1 Crystalline 2- `(2-aminoethoxy) methyl!-4-(2-chlorophenyl) -3-ethoxycarbonyl-5-methoxycarbonyl-6- methyl-1, 4-dihydropyridine maleate salt (amplodipine) |
| 04/22/2004 | WO2004033428A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/22/2004 | WO2004033427A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | WO2004033426A2 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 04/22/2004 | WO2004033424A1 Watersoluble prodrugs of propofol |
| 04/22/2004 | WO2004020410A3 Dihydropyridinone derivatives as hne inhibitors |
| 04/22/2004 | WO2003101958A3 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 04/22/2004 | US20040077900 Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077865 Making 1-amino-6-nitroisoquinoline by reacting beta-(dimethylamino)-2-cyano-5-nitro-styrene with lithium hexamethyldisilazane or reacting said styrene compound with 2,4-dimethoxybenzylamine and then with anisole |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077683 Polymorphism; recrystallizing fexofenadine in alkanol; azeotropically refluxing in solvent; stirring |
| 04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |
| 04/22/2004 | US20040077635 Trypsin-like serine protease inhibitors; treating thromboembolic disorders; anticoagulants |
| 04/22/2004 | US20040077555 Substituted benzene derivatives or salts thereof |
| 04/22/2004 | US20040076774 Ink jet recording material |
| 04/22/2004 | US20040074417 Ink-jet ink, an ink-jet recording material or an ink-jet system containing at least one water-soluble hindered amine compounds of the general formula (I) or (II): wherein G1 and G2 are independently alkyl of (1) to (4) carbon atoms or |
| 04/22/2004 | CA2501611A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | CA2501534A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 04/21/2004 | EP1410921A1 Ink jet recording material and light-stabilising compound |
| 04/21/2004 | EP1409691A2 Stereoselective preparation of cyclic l-amino acids |
| 04/21/2004 | EP1409479A2 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1409458A1 Method for preparing 4-amino-4-phenylpiperidines |
| 04/21/2004 | EP1409457A1 Method for preparing 4-methylamino-4-phenylpiperidine |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1408965A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 04/21/2004 | EP1320525B1 Antibacterial mutilins |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/21/2004 | CN1491105A Novel modified released formulation |
| 04/21/2004 | CN1491104A Novel modified release formulation |
| 04/21/2004 | CN1146563C Piperidinylmethyloxazolidinone derivative |
| 04/21/2004 | CN1146540C Novel compound with analgesic effect and use thereof |
| 04/20/2004 | USRE38506 Potent inducers of terminal differentiation and methods of use thereof |
| 04/20/2004 | US6723729 Chemical intermediates for anticarcinogenic agent irinotecan |
| 04/20/2004 | CA2215585C Practical synthesis of urea derivatives |
| 04/15/2004 | WO2004031172A1 Piperidine derivatives as ccr5 inhibitors |
| 04/15/2004 | WO2004031149A1 Substituted gamma-phenyl-delta-lactams and uses related thereto |
| 04/15/2004 | WO2004031148A1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 04/15/2004 | WO2004031145A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 04/15/2004 | WO2004031138A1 Novel sulphones for inhibition of gamma secretase |
| 04/15/2004 | WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 04/15/2004 | WO2004031125A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | WO2004030668A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004013100A3 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 04/15/2004 | WO2003080631A3 Plasma carboxypeptidase b inhibitors |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2002048108A9 New process for the preparation diaryl-4-amino-piperidinyl compounds |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040073038 Antidepressants; serotonine uptake inhibitors |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040072879 Calcium channel blockers; antiischemic agents; hypotensive agents |